SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-029650
Filing Date
2022-08-24
Accepted
2022-08-24 20:17:54
Documents
1
Period of Report
2022-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 26482
  Complete submission text file 0000899243-22-029650.txt   27847
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PURE BIOSCIENCE 1725 GILLESPIE WAY EL CAJON CA 92020
Business Address
Johnson Craig A (Reporting) CIK: 0001370348 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 221192697